| Product Code: ETC6525448 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of drug-device combination products into Brunei in 2024 saw a notable concentration of suppliers, with Malaysia, Singapore, Ireland, USA, and Australia dominating the market. The Herfindahl-Hirschman Index (HHI) indicating market concentration surged from high to very high in 2024, reflecting a competitive landscape. Despite a significant decline in the compound annual growth rate (CAGR) from 2020 to 2024 at -12.13%, the marginal decrease in growth rate from 2023 to 2024 at -5.61% suggests a more stable market performance in the most recent year.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Brunei Drug-Device Combination Products Market Overview |
3.1 Brunei Country Macro Economic Indicators |
3.2 Brunei Drug-Device Combination Products Market Revenues & Volume, 2022 & 2032F |
3.3 Brunei Drug-Device Combination Products Market - Industry Life Cycle |
3.4 Brunei Drug-Device Combination Products Market - Porter's Five Forces |
3.5 Brunei Drug-Device Combination Products Market Revenues & Volume Share, By Product, 2022 & 2032F |
3.6 Brunei Drug-Device Combination Products Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.7 Brunei Drug-Device Combination Products Market Revenues & Volume Share, By End user, 2022 & 2032F |
4 Brunei Drug-Device Combination Products Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Brunei leading to higher demand for drug-device combination products. |
4.2.2 Technological advancements in drug-device combination products improving efficacy and patient outcomes. |
4.2.3 Government initiatives promoting the adoption of innovative healthcare solutions in Brunei. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval and commercialization of drug-device combination products in Brunei. |
4.3.2 Limited awareness and understanding among healthcare professionals and patients about the benefits of drug-device combination products. |
4.3.3 High initial investment costs associated with the development and manufacturing of drug-device combination products. |
5 Brunei Drug-Device Combination Products Market Trends |
6 Brunei Drug-Device Combination Products Market, By Types |
6.1 Brunei Drug-Device Combination Products Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Brunei Drug-Device Combination Products Market Revenues & Volume, By Product, 2022 - 2032F |
6.1.3 Brunei Drug-Device Combination Products Market Revenues & Volume, By Drug-eluting stents, 2022 - 2032F |
6.1.4 Brunei Drug-Device Combination Products Market Revenues & Volume, By Infusion pumps, 2022 - 2032F |
6.1.5 Brunei Drug-Device Combination Products Market Revenues & Volume, By Photodynamic therapy, 2022 - 2032F |
6.1.6 Brunei Drug-Device Combination Products Market Revenues & Volume, By Antimicrobial wound dressings, 2022 - 2032F |
6.1.7 Brunei Drug-Device Combination Products Market Revenues & Volume, By Prefilled syringes, 2022 - 2032F |
6.1.8 Brunei Drug-Device Combination Products Market Revenues & Volume, By Drug-eluting balloons, 2022 - 2032F |
6.1.9 Brunei Drug-Device Combination Products Market Revenues & Volume, By Other, 2022 - 2032F |
6.1.10 Brunei Drug-Device Combination Products Market Revenues & Volume, By Other, 2022 - 2032F |
6.2 Brunei Drug-Device Combination Products Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Brunei Drug-Device Combination Products Market Revenues & Volume, By Cardiovascular Disorders, 2022 - 2032F |
6.2.3 Brunei Drug-Device Combination Products Market Revenues & Volume, By Diabetes, 2022 - 2032F |
6.2.4 Brunei Drug-Device Combination Products Market Revenues & Volume, By Respiratory Problems, 2022 - 2032F |
6.2.5 Brunei Drug-Device Combination Products Market Revenues & Volume, By Cancer Treatment, 2022 - 2032F |
6.2.6 Brunei Drug-Device Combination Products Market Revenues & Volume, By Antimicrobial Application, 2022 - 2032F |
6.2.7 Brunei Drug-Device Combination Products Market Revenues & Volume, By Other, 2022 - 2032F |
6.3 Brunei Drug-Device Combination Products Market, By End user |
6.3.1 Overview and Analysis |
6.3.2 Brunei Drug-Device Combination Products Market Revenues & Volume, By Hospital & clinic, 2022 - 2032F |
6.3.3 Brunei Drug-Device Combination Products Market Revenues & Volume, By Ambulatory surgery center (asc), 2022 - 2032F |
6.3.4 Brunei Drug-Device Combination Products Market Revenues & Volume, By Home care setting, 2022 - 2032F |
6.3.5 Brunei Drug-Device Combination Products Market Revenues & Volume, By Other, 2022 - 2032F |
7 Brunei Drug-Device Combination Products Market Import-Export Trade Statistics |
7.1 Brunei Drug-Device Combination Products Market Export to Major Countries |
7.2 Brunei Drug-Device Combination Products Market Imports from Major Countries |
8 Brunei Drug-Device Combination Products Market Key Performance Indicators |
8.1 Number of clinical trials and research studies conducted on drug-device combination products in Brunei. |
8.2 Adoption rate of drug-device combination products by healthcare facilities and practitioners in Brunei. |
8.3 Rate of reimbursement and insurance coverage for drug-device combination products in Brunei. |
9 Brunei Drug-Device Combination Products Market - Opportunity Assessment |
9.1 Brunei Drug-Device Combination Products Market Opportunity Assessment, By Product, 2022 & 2032F |
9.2 Brunei Drug-Device Combination Products Market Opportunity Assessment, By Application, 2022 & 2032F |
9.3 Brunei Drug-Device Combination Products Market Opportunity Assessment, By End user, 2022 & 2032F |
10 Brunei Drug-Device Combination Products Market - Competitive Landscape |
10.1 Brunei Drug-Device Combination Products Market Revenue Share, By Companies, 2025 |
10.2 Brunei Drug-Device Combination Products Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here